This review outlines comprehensive anesthetic considerations for patients undergoing gynecologic cancer surgery, emphasizing the importance of preoperative assessment and tailored intraoperative and postoperative management.
Answers are grounded in this paper and cite their sources.
May guide perioperative strategies in gynecologic cancer surgery; leaves open need for prospective validation of protocols.
Preoperative, intraoperative, and postoperative anesthetic considerations in gynecologic cancer surgery are discussed. Preoperatively, the anesthetist must document the patient's disease state, physical condition, responses to prior chemotherapeutic regimens and toxic side effects, particularly from Adriamycin and bleomycin. Laboratory studies should include electrolytes, hepatic, renal, and hematologic indices. The anesthetist should also recognize that patients may be under great emotional stress, which may require prescribing anti-anxiety medications for several days prior to surgery. Planning the anesthetic includes consultation with the surgeon relative to procedure planned, positioning requirements, anticipated blood loss, monitoring and postoperative care requirements. Intraoperative considerations again involve close communication with the surgeon. The use and benefits of a combined regional/general anesthetic technique are discussed. Postoperative considerations are directed toward hemodynamic stability and control of postoperative pain. Techniques of epidural narcotic and local anesthetic administration, as well as patient-controlled analgesia (PCA) are discussed.
No takes yet. Share an insight, caveat, or question.
Powell et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: